These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 34291391)

  • 1. Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies.
    Squire JD; Joshi AY
    J Clin Immunol; 2021 Oct; 41(7):1527-1530. PubMed ID: 34291391
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell-oriented strategies for controlling the COVID-19 pandemic.
    Noh JY; Jeong HW; Kim JH; Shin EC
    Nat Rev Immunol; 2021 Nov; 21(11):687-688. PubMed ID: 34497383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Open Letter: COVID-19 and Cancer.
    Printz C
    Cancer; 2021 Apr; 127(8):1171. PubMed ID: 33878202
    [No Abstract]   [Full Text] [Related]  

  • 4. Covid-19 challenges to immune investigations and therapies.
    Talmadge JE; Marceau F
    Int Immunopharmacol; 2021 Jun; 95():107543. PubMed ID: 33735717
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 vaccines: acting on the evidence.
    Nat Med; 2021 Feb; 27(2):183. PubMed ID: 33542537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
    Terpos E; Trougakos IP; Apostolakou F; Charitaki I; Sklirou AD; Mavrianou N; Papanagnou ED; Liacos CI; Gumeni S; Rentziou G; Korompoki E; Papassotiriou I; Dimopoulos MA
    Am J Hematol; 2021 Jul; 96(7):E257-E259. PubMed ID: 33837984
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer Centers, Organizations Call for COVID-19 Vaccine for Patients With Cancer, Survivors.
    Printz C
    Cancer; 2021 Apr; 127(8):1170-1171. PubMed ID: 33878201
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccinology - Editorial.
    Pizza M; Rappuoli R
    Semin Immunol; 2020 Aug; 50():101439. PubMed ID: 33298400
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 Australia: Epidemiology Report 41: Reporting period ending 9 May 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 May; 45():. PubMed ID: 34074235
    [No Abstract]   [Full Text] [Related]  

  • 11. The Immunologists' Guide to Pandemic Preparedness.
    Marín-Hernández D; Hupert N; Nixon DF
    Trends Immunol; 2021 Feb; 42(2):91-93. PubMed ID: 33358277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Australia: Epidemiology Report 40: Reporting period ending 25 April 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 May; 45():. PubMed ID: 34074231
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.
    Ehmsen S; Asmussen A; Jeppesen SS; Nilsson AC; Østerlev S; Vestergaard H; Justesen US; Johansen IS; Frederiksen H; Ditzel HJ
    Cancer Cell; 2021 Aug; 39(8):1034-1036. PubMed ID: 34348121
    [No Abstract]   [Full Text] [Related]  

  • 14. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 Australia: Epidemiology Report 45 Reporting period ending 4 July 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 Jul; 45():. PubMed ID: 34281495
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
    Zollner A; Watschinger C; Rössler A; Farcet MR; Penner A; Böhm V; Kiechl SJ; Stampfel G; Hintenberger R; Tilg H; Koch R; Antlanger M; Kreil TR; Kimpel J; Moschen AR
    EBioMedicine; 2021 Aug; 70():103539. PubMed ID: 34391087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination.
    Dages KN; Pitlick MM; Joshi AY; Park MA
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):257-258. PubMed ID: 33962029
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement Factors in COVID-19 Therapeutics and Vaccines.
    Kurtovic L; Beeson JG
    Trends Immunol; 2021 Feb; 42(2):94-103. PubMed ID: 33402318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.